Oi S, Ciric I S
No Shinkei Geka. 1982 Nov;10(11):1183-7.
Fifty-nine pituitary adenomas treated with transsphenoidal approach were analyzed in the light of visual field defects and the postoperative cure rates. Twenty-six cases had visual field defects. The majority of the defects were temporal 1/2 or superior 1/4, although atypical deficits such as incongruous homonymous hemianopsia, nasal 1/2 defect, superior 1/2 defect, peripheral constrict were seen. The visual field defects were correlated with the size of the tumor in Hardy and Vezina classification of the suprasellar extension. The visual field defects appeared in 100% of Type C, 89% of Type B, 50% of Type A, 0% of Type O. In 24 out of 26 patients with preoperative visual field defect, the visual field improved either to normal or wider fields postoperatively. There were 9 patients with optic atrophy, which also showed the correlation with the tumor size. Only the tumor of Type B or C revealed optic atrophy but still 45.4% patients in this group had no optic atrophy. The visual field defect in 85% of the patients without optic atrophy improved to normal post-operatively, while 66% with mild and only 20% with severe optic atrophy showed complete recovery. In conclusions, authors emphasize followings. 1) Improvement rate in the visual field defect of pituitary adenomas by transsphenoidal approach was superior to the previously reported rates by transcranial operations. 2) The factors affecting the functional prognosis in the visual field defect are the natures of the tumor, surgical approach and the factors affecting the plasticity of the optic nerves. The existence and degree of optic atrophy could be one of the references for the plasticity of the optic nerves. 3) There is a close relation between the morphological potential of the tumor and optic atrophy/visual field defect. From these standpoints of view, the early diagnosis and treatment should be emphasized.
对59例经蝶窦入路治疗的垂体腺瘤,根据视野缺损情况和术后治愈率进行分析。26例有视野缺损。多数缺损为颞侧1/2或上象限1/4,不过也可见不典型缺损,如不一致性同侧偏盲、鼻侧1/2缺损、上象限1/2缺损、周边视野缩窄。视野缺损与Hardy和Vezina鞍上扩展分类中肿瘤大小相关。C型肿瘤视野缺损出现率为100%,B型为89%,A型为50%,O型为0%。26例术前有视野缺损的患者中,24例术后视野改善至正常或视野变宽。有9例视神经萎缩患者,也显示出与肿瘤大小相关。仅B型或C型肿瘤出现视神经萎缩,但该组仍有45.4%的患者没有视神经萎缩。85%没有视神经萎缩的患者术后视野缺损改善至正常,而轻度视神经萎缩患者中66%、重度视神经萎缩患者中仅20%显示完全恢复。总之,作者强调以下几点。1)经蝶窦入路治疗垂体腺瘤视野缺损的改善率优于先前报道的经颅手术率。2)影响视野缺损功能预后的因素包括肿瘤性质、手术入路以及影响视神经可塑性的因素。视神经萎缩的存在及程度可为视神经可塑性的参考指标之一。3)肿瘤的形态学潜能与视神经萎缩/视野缺损之间存在密切关系。从这些观点出发,应强调早期诊断和治疗。